* Link to Danish study: https://t.co/QNduPxQ0nb Actually a cohort study not case-controlled.
Long-Term Adverse Cardiac Outcomes in Patients With Sarcoidosis https://t.co/qkRbKXHjGi
RT @tripdatabase: New2Trip: Long-Term Adverse Cardiac Outcomes in Patients w/ Sarcoidosis https://t.co/q47R8uSUEH
RT @tripdatabase: New2Trip: Long-Term Adverse Cardiac Outcomes in Patients w/ Sarcoidosis https://t.co/q47R8uSUEH
New2Trip: Long-Term Adverse Cardiac Outcomes in Patients w/ Sarcoidosis https://t.co/q47R8uSUEH
New2Trip: Long-Term Adverse Cardiac Outcomes in Patients w/ Sarcoidosis https://t.co/q47R8uSUEH
RT @ngilotraMD: Important study highlighting cardiac implications of sarcoidosis. Recognizing cardiac involvement is key! So much to learn…
RT @ngilotraMD: Important study highlighting cardiac implications of sarcoidosis. Recognizing cardiac involvement is key! So much to learn…
Long-term adverse cardiad outcomes in patients with sarcoid https://t.co/jL6NrThO1d
RT @JACCJournals: Long-term follow-up in sarcoidosis patients: more #heartfailure, arrhythmia, and adverse outcomes. Learn more in #JACC: h…
RT @JACCJournals: Long-term follow-up in sarcoidosis patients: more #heartfailure, arrhythmia, and adverse outcomes. Learn more in #JACC: h…
RT @ngilotraMD: Important study highlighting cardiac implications of sarcoidosis. Recognizing cardiac involvement is key! So much to learn…
RT @ngilotraMD: Important study highlighting cardiac implications of sarcoidosis. Recognizing cardiac involvement is key! So much to learn…
RT @ngilotraMD: Important study highlighting cardiac implications of sarcoidosis. Recognizing cardiac involvement is key! So much to learn…
Important study highlighting cardiac implications of sarcoidosis. Recognizing cardiac involvement is key! So much to learn in this exciting field…! @hopkinsheart @EdKasper3 @JonChrispinMD @KSharmaMD @stevenhsu_md @JACCJournals https://t.co/5vnpoOkmD5 htt
RT @CopCard: A Yafasova, J Butt et al found the10y risk in #sarcoidosis pts vs. BG pop was 💔 #heartfailure 3.2% vs 1.7% 💀All cause mortal…
RT @BrettSperryMD: Nice population based study from Denmark showing 2x more incident #heartfailure in the sarcoidosis population vs control…
Nice population based study from Denmark showing 2x more incident #heartfailure in the sarcoidosis population vs controls. Also higher rates of arrhythmias and all-cause mortality. This highlights the need for a multidisciplinary approach in #sarcoidosis
RT @JACCJournals: Long-term follow-up in sarcoidosis patients: more #heartfailure, arrhythmia, and adverse outcomes. Learn more in #JACC: h…
Long-Term Adverse Cardiac Outcomes in Patients With Sarcoidosis | JACC: Journal of the American College of Cardiology https://t.co/UlsZju82Y4
An unfortunate trend - as I think of outpatients with cardiac sarcoidosis. #JACC #Cardiotwitter @JACCJournals
RT @JACCJournals: Long-term follow-up in sarcoidosis patients: more #heartfailure, arrhythmia, and adverse outcomes. Learn more in #JACC: h…
RT @JACCJournals: Long-term follow-up in sarcoidosis patients: more #heartfailure, arrhythmia, and adverse outcomes. Learn more in #JACC: h…
RT @JACCJournals: Long-term follow-up in sarcoidosis patients: more #heartfailure, arrhythmia, and adverse outcomes. Learn more in #JACC: h…
RT @JACCJournals: Long-term follow-up in sarcoidosis patients: more #heartfailure, arrhythmia, and adverse outcomes. Learn more in #JACC: h…
RT @JACCJournals: Long-term follow-up in sarcoidosis patients: more #heartfailure, arrhythmia, and adverse outcomes. Learn more in #JACC: h…
Absolute 10-year risks of ♥️outcomes for Sarcoidosis vs background ✅HF: 3.2% vs 1.7% ✅ICD, ventricular arrhythmias, cardiac arrest: 1% vs 0.5% ✅composite of pacemaker, AV block, sinoatrial dysfunction: 1% vs 0.5% ✅AF or flutter: 3.4% vs 2.7% ✅all-cause mor
RT @JACCJournals: Long-term follow-up in sarcoidosis patients: more #heartfailure, arrhythmia, and adverse outcomes. Learn more in #JACC: h…
RT @JACCJournals: Long-term follow-up in sarcoidosis patients: more #heartfailure, arrhythmia, and adverse outcomes. Learn more in #JACC: h…
Interesting Danish study of pts with Sarcoidosis vs. no Sarcoidosis: Sarcoidosis more #HeartFailure, more #Af_Afl, and higher mortality. Excellent data in #JACC DOI: 10.1016/j.jacc.2020.06.038 https://t.co/rQeUep4xgP
RT @JACCJournals: Long-term follow-up in sarcoidosis patients: more #heartfailure, arrhythmia, and adverse outcomes. Learn more in #JACC: h…
RT @JACCJournals: Long-term follow-up in sarcoidosis patients: more #heartfailure, arrhythmia, and adverse outcomes. Learn more in #JACC: h…
@julie_shade
RT @JACCJournals: Long-term follow-up in sarcoidosis patients: more #heartfailure, arrhythmia, and adverse outcomes. Learn more in #JACC: h…
RT @JACCJournals: Long-term follow-up in sarcoidosis patients: more #heartfailure, arrhythmia, and adverse outcomes. Learn more in #JACC: h…
RT @JACCJournals: Long-term follow-up in sarcoidosis patients: more #heartfailure, arrhythmia, and adverse outcomes. Learn more in #JACC: h…
RT @JACCJournals: Long-term follow-up in sarcoidosis patients: more #heartfailure, arrhythmia, and adverse outcomes. Learn more in #JACC: h…
RT @JACCJournals: Long-term follow-up in sarcoidosis patients: more #heartfailure, arrhythmia, and adverse outcomes. Learn more in #JACC: h…
Routine echo plus EKG/Holter probably not enough: Biomarkers plus cardiac MRI at least at baseline?
RT @JACCJournals: Long-term follow-up in sarcoidosis patients: more #heartfailure, arrhythmia, and adverse outcomes. Learn more in #JACC: h…
RT @JACCJournals: Long-term follow-up in sarcoidosis patients: more #heartfailure, arrhythmia, and adverse outcomes. Learn more in #JACC: h…
RT @JACCJournals: Long-term follow-up in sarcoidosis patients: more #heartfailure, arrhythmia, and adverse outcomes. Learn more in #JACC: h…
Long-term follow-up in sarcoidosis patients: more #heartfailure, arrhythmia, and adverse outcomes. Learn more in #JACC: https://t.co/jyNu55E3Pl https://t.co/MXYpqOvcPw
RT @Yuki_Sahashi: ・新規診断のサルコイドーシス12000例のレジストリ(デンマーク) ・10年のフォローで心不全は3%程度 心肺停止1%程度 ・マッチペアの相手は心臓突然死ハイリスク患者で比較 Long-Term Adverse Cardiac Outcom…
Long-Term Adverse Cardiac Outcomes in Patients With Sarcoidosis. https://t.co/4Cf1IGbfdg
Los pacientes con sarcoidosis tendrían mayor riesgo asociado de insuficiencia cardíaca y otros resultados cardíacos adversos https://t.co/3Lbehnfnu3
RT @JACCJournals: Sarcoidosis: A risk factor for #heartfailure? Learn with #JACC. https://t.co/jyNu55E3Pl https://t.co/rhLCSpx6Nj
RT @BSHeartFailure: Effect of sarcoidosis on long-term cardiovascular risk: 3.2% risk of HF at 10 years (1.7% in matched controls). PPM, AV…
RT @ArashArya_EP: #EPeeps Long-Term Adverse Cardiac Outcomes in Patients With Sarcoidosis https://t.co/1qld59Csk8 https://t.co/viVfkEOz35
#EPeeps Long-Term Adverse Cardiac Outcomes in Patients With Sarcoidosis https://t.co/1qld59Csk8 https://t.co/viVfkEOz35
RT @BSHeartFailure: Effect of sarcoidosis on long-term cardiovascular risk: 3.2% risk of HF at 10 years (1.7% in matched controls). PPM, AV…
RT @BSHeartFailure: Effect of sarcoidosis on long-term cardiovascular risk: 3.2% risk of HF at 10 years (1.7% in matched controls). PPM, AV…
RT @Yuki_Sahashi: ・新規診断のサルコイドーシス12000例のレジストリ(デンマーク) ・10年のフォローで心不全は3%程度 心肺停止1%程度 ・マッチペアの相手は心臓突然死ハイリスク患者で比較 Long-Term Adverse Cardiac Outcom…
RT @Yuki_Sahashi: ・新規診断のサルコイドーシス12000例のレジストリ(デンマーク) ・10年のフォローで心不全は3%程度 心肺停止1%程度 ・マッチペアの相手は心臓突然死ハイリスク患者で比較 Long-Term Adverse Cardiac Outcom…
RT @Yuki_Sahashi: ・新規診断のサルコイドーシス12000例のレジストリ(デンマーク) ・10年のフォローで心不全は3%程度 心肺停止1%程度 ・マッチペアの相手は心臓突然死ハイリスク患者で比較 Long-Term Adverse Cardiac Outcom…
RT @BSHeartFailure: Effect of sarcoidosis on long-term cardiovascular risk: 3.2% risk of HF at 10 years (1.7% in matched controls). PPM, AV…
RT @JACCJournals: Sarcoidosis: A risk factor for #heartfailure? Learn with #JACC. https://t.co/jyNu55E3Pl https://t.co/rhLCSpx6Nj
RT @CopCard: A Yafasova, J Butt et al found the10y risk in #sarcoidosis pts vs. BG pop was 💔 #heartfailure 3.2% vs 1.7% 💀All cause mortal…
RT @jeanlucvachiery: Oh definitely!! @RyanTedfordMD @FH_Verbrugge
RT @CopCard: A Yafasova, J Butt et al found the10y risk in #sarcoidosis pts vs. BG pop was 💔 #heartfailure 3.2% vs 1.7% 💀All cause mortal…
A Yafasova, J Butt et al found the10y risk in #sarcoidosis pts vs. BG pop was 💔 #heartfailure 3.2% vs 1.7% 💀All cause mortality 10.9% vs 7.4% @JACCJournals paper 📰https://t.co/sse92Qgxmq @Medscape article here 🗞️https://t.co/2Fj13CSyll #cardiotwitter
RT @BSHeartFailure: Effect of sarcoidosis on long-term cardiovascular risk: 3.2% risk of HF at 10 years (1.7% in matched controls). PPM, AV…
Oh definitely!! @RyanTedfordMD @FH_Verbrugge
Effect of sarcoidosis on long-term cardiovascular risk: 3.2% risk of HF at 10 years (1.7% in matched controls). PPM, AV block, and SA dysfunction: 0.94% (0.51% in controls). JACC 2020 https://t.co/W84nRtJQMt
RT @JACCJournals: Sarcoidosis: A risk factor for #heartfailure? Learn with #JACC. https://t.co/jyNu55E3Pl https://t.co/rhLCSpx6Nj
RT @JACCJournals: Sarcoidosis: A risk factor for #heartfailure? Learn with #JACC. https://t.co/jyNu55E3Pl https://t.co/rhLCSpx6Nj
RT @JACCJournals: Sarcoidosis: A risk factor for #heartfailure? Learn with #JACC. https://t.co/jyNu55E3Pl https://t.co/rhLCSpx6Nj
RT @JACCJournals: Sarcoidosis: A risk factor for #heartfailure? Learn with #JACC. https://t.co/jyNu55E3Pl https://t.co/rhLCSpx6Nj
RT @JACCJournals: Sarcoidosis: A risk factor for #heartfailure? Learn with #JACC. https://t.co/jyNu55E3Pl https://t.co/rhLCSpx6Nj
RT @JACCJournals: Sarcoidosis: A risk factor for #heartfailure? Learn with #JACC. https://t.co/jyNu55E3Pl https://t.co/rhLCSpx6Nj
RT @JACCJournals: Sarcoidosis: A risk factor for #heartfailure? Learn with #JACC. https://t.co/jyNu55E3Pl https://t.co/rhLCSpx6Nj
RT @JACCJournals: Sarcoidosis: A risk factor for #heartfailure? Learn with #JACC. https://t.co/jyNu55E3Pl https://t.co/rhLCSpx6Nj
RT @JACCJournals: Sarcoidosis: A risk factor for #heartfailure? Learn with #JACC. https://t.co/jyNu55E3Pl https://t.co/rhLCSpx6Nj
Sarcoidosis: A risk factor for #heartfailure? Learn with #JACC. https://t.co/jyNu55E3Pl https://t.co/rhLCSpx6Nj
Long-Term Adverse Cardiac Outcomes in Patients With Sarcoidosis | JACC: Journal of the American College of Cardiology https://t.co/UlsZju82Y4
RT @JTLLERGO: ⚠️ Long-Term Adverse Cardiac Outcomes in Patients With Sarcoidosis. Absolute 10-year risks: ‼️HF 3.18% vs 1.72% ‼️ All-cause…
RT @JTLLERGO: ⚠️ Long-Term Adverse Cardiac Outcomes in Patients With Sarcoidosis. Absolute 10-year risks: ‼️HF 3.18% vs 1.72% ‼️ All-cause…
⚠️ Long-Term Adverse Cardiac Outcomes in Patients With Sarcoidosis. Absolute 10-year risks: ‼️HF 3.18% vs 1.72% ‼️ All-cause mortality 10.88% vs 7.43% https://t.co/qqbmHAnGRT https://t.co/EdVuWIfR91